Technical Analysis for EIGR - Eiger BioPharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Narrow Range Bar | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Calm After Storm | Range Contraction | -9.21% | |
NR7 | Range Contraction | -9.21% | |
Narrow Range Bar | Range Contraction | -9.21% | |
Wide Bands | Range Expansion | -9.21% | |
Oversold Stochastic | Weakness | -9.21% | |
Calm After Storm | Range Contraction | -18.25% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a portfolio of late-stage drugs for orphan diseases. It offers Sarasar, which is used for the treatment of hepatitis delta; Exendin that is used for the treatment of hypoglycemia; and Bestatin, which is used for the treatment of pulmonary arterial hypertension and lymphedema. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is based in Palo Alto, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmacy Hypertension Hepatitis Specialty Drugs Pulmonary Arterial Hypertension Orphan Disease Pulmonary Hypertension Treatment Of Hepatitis Lymphedema Hypoglycemia
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmacy Hypertension Hepatitis Specialty Drugs Pulmonary Arterial Hypertension Orphan Disease Pulmonary Hypertension Treatment Of Hepatitis Lymphedema Hypoglycemia
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 43.35 |
52 Week Low | 1.1 |
Average Volume | 139,801 |
200-Day Moving Average | 11.59 |
50-Day Moving Average | 5.29 |
20-Day Moving Average | 3.95 |
10-Day Moving Average | 2.46 |
Average True Range | 0.84 |
RSI (14) | 28.57 |
ADX | 22.97 |
+DI | 18.90 |
-DI | 32.38 |
Chandelier Exit (Long, 3 ATRs) | 4.74 |
Chandelier Exit (Short, 3 ATRs) | 3.62 |
Upper Bollinger Bands | 7.50 |
Lower Bollinger Band | 0.41 |
Percent B (%b) | 0.19 |
BandWidth | 179.30 |
MACD Line | -1.13 |
MACD Signal Line | -0.90 |
MACD Histogram | -0.2297 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.09 | ||||
Resistance 3 (R3) | 2.10 | 2.00 | 2.03 | ||
Resistance 2 (R2) | 2.00 | 1.91 | 1.99 | 2.00 | |
Resistance 1 (R1) | 1.86 | 1.85 | 1.81 | 1.85 | 1.98 |
Pivot Point | 1.76 | 1.76 | 1.74 | 1.75 | 1.76 |
Support 1 (S1) | 1.62 | 1.67 | 1.57 | 1.61 | 1.47 |
Support 2 (S2) | 1.52 | 1.61 | 1.51 | 1.45 | |
Support 3 (S3) | 1.38 | 1.52 | 1.43 | ||
Support 4 (S4) | 1.37 |